Bio

John Rumsey, Managing Director, is based in Aquilo Partner's San Francisco office. He brings over 30 years of life science investment banking expertise, specializing in biotechnology, specialty pharma, and medical devices. Prior to co-founding Aquilo Partners, John spent 12 years in life science investment banking at Hambrecht & Quist and PaineWebber. He began his career in 1989 in investment banking at PaineWebber Development Corporation, which provided capital to leading biotechnology companies such as Alkermes, Amgen, Centocor, Cephalon, Genentech, Genzyme and Repligen. In 1994, John joined Hambrecht & Quist, where he continued to focus on life sciences and worked extensively in biotechnology, specialty pharma and medical devices. His clients at H&Q included Cephalon, Centocor, Connectics, Darwin, Dura, Durect, EVT, Genzyme, Gilead, Incyte, Intermune, Invitrogen, i-STAT, Khepri, King, Ligand, Medicis, Novoste, SangStat, Shire, Sugen, Unimed, and Versicor (Vicuron). John received a BA degree from Williams College.